Following the publication of new data on the use of progesterone to support the luteal phase, it would be interesting to get an update on how you are currently practicing. The results obtained from the luteal phase support survey conducted a few months ago and this one will be published together on IVF-Worldwide.
If you support the luteal phase, when do you start the regimen you use?
- On the day of hCG administration
- On the day after hCG administration
- On the day of egg collection
- On the day after egg collection
- On the day of embryo transfer
- A few days after embryo transfer
- Other
- I do not support the luteal phase
Until how many weeks after embryo transfer do you continue progesterone supplementation if the patient conceives?
- Until pregnancy is confirmed in a blood or urine test (week 4) or until 14 days after embryo transfer
- Until the presence of a fetal heartbeat
- Until gestational week 8–10
- Until gestational week 12
- Beyond 12 weeks
- I do not administer progesterone
In the majority of the cases, what is your treatment agent/route of choice to support the luteal phase?
- hCG
- Vaginal progesterone
- IM progesterone
- Subcutaneous progesterone
- Oral progesterone
- GnRH agonist nasal spray
- A combination of the drugs/routes mentioned above
- Other
- I do not support the luteal phase
If you use a combination of progesterone treatments, which do you prefer?
- Vaginal and IM/subcutaneous progesterone
- Vaginal and oral progesterone
- IM/subcutaneous and oral progesterone
- Vaginal, IM/subcutaneous and oral progesterone
- Other
- I do not use a combination of progesterone treatments
- I do not support the luteal phase
If your patients fails the first cycle, how will you change the progesterone treatment from the 2nd cycle onwards?
- Add one more progesterone medication
- Change the progesterone medication
- Remain with the same progesterone treatment
- I do not support the luteal phase
- Other
If you use oral progesterone, which drug do you prefer?
- Micronized progesterone (such as Utrogestan)
- Medroxyprogesterone acetate (such as Provera)
- Dydrogesterone (such as Duphaston)
- Norethisterone (such as Primolut-Nor)
- I do not use oral progesterone
If all progesterone formulations were found to yield the same live birth rates, which route would you prefer to use?
- Oral
- Vaginal
- Subcutaneous
- IM
- Rectal
- No preference
Are you aware of published studies supporting oral routes for luteal support?
- Yes, there is sufficient data
- There is some data, but I would like to see more evidence
- No, I am not aware of published studies
Do you routinely (in more than 30% of patients) measure progesterone levels during the supplemented luteal phase?
- Yes
- No
- I only measure in individually selected cases
If you routinely measure progesterone during the luteal phase, do you modify treatment according to the results?
- I do not measure progesterone during the luteal phase
- Yes, I may lower the dose
- Yes, I may increase the dose
- Yes, I may add additional progesterone to the regimen
- No, I do not modify treatment. I only keep the data for possible future use
In your opinion, which progesterone administration route would women prefer?
- Oral
- Subcutaneous
- Rectal
- No preference or do not know
Do you advise patients to avoid sexual intercourse during the luteal phase if they are using vaginal progesterone?
- Yes
- No
- I do not speak with patients about sexual intercourse during the luteal phase
How much do you hear about inconvenience to patients’ daily lives while they are treated with vaginal progesterone medications for the luteal phase?
- Patients do not complain
- Few patients complain (Less than 10%)
- Some patients complain (10% - 30%)
- Many patients complain (more than 30%)
- I do not know
- Patients may complain to nurses or other members of my team, but I have not heard of this
- Other
